Federal grants to Neurogt Inc
Neurogt Inc in Durham, North Carolina received $6.9 million in federal grants from fiscal 2021 to 2025, across 7 awards. Its largest program was Extramural Research Programs in the Neurosciences and Neurological Disorders, with $3.9 million. In fiscal 2025 it was awarded $4.1 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$6.9 million
- Awards7
- Awarded in FY 2025$4.1 million
- Largest award$2.3 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $284,425 |
| FY 2022 | 1 | $378,882 |
| FY 2023 | 2 | $630,302 |
| FY 2024 | 2 | $1.5 million |
| FY 2025 | 5 | $4.1 million |
Programs that fund Neurogt Inc
| Program | Awards | Amount |
|---|---|---|
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 5 | $3.9 million |
| Allergy and Infectious Diseases Research | 1 | $2.3 million |
| Research Infrastructure Programs | 1 | $722,587 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 7 | $6.9 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Protein depleting pre-existing antibodies for viral gene therapy - project summary: this is a fast-track sbir grant proposal. As effective gene therapy (GT) products using adeno-associated viral (AAV) vectors advance to clinical applications, the translation faces critical challenge of high prevalen | Allergy and Infectious Diseases Research | July 27, 2023 | $2.3 million |
| Development of gene therapy product for treating mps iiib - project summary the goal of this fast-track sbir project is to further develop aav gene therapy product for treating mucopolysaccharidosis (MPS) iiib towards clinical application and commercialization. Mps iiib, is a rare autosomal recessiv | Extramural Research Programs in the Neurosciences and Neurological Disorders | August 30, 2024 | $1.8 million |
| Trans-bbb AAV9 gene therapy targeting cns neuropathy of mps i - project summary the goal of this phase II sbir project is to further develop an effective gene replacement therapy product for treating mucopolysaccharidosis (MPS) i, towards clinical application and commercialization. Mps i is a rare l | Extramural Research Programs in the Neurosciences and Neurological Disorders | September 16, 2025 | $776,917 |
| Trans-bbb AAV9 gene therapy targeting cns neuropathy of mps i - project summary the goal of this phase II sbir project is to further develop an effective gene replacement therapy product for treating mucopolysaccharidosis (MPS) i, towards clinical application and commercialization. Mps i is a rare l | Research Infrastructure Programs | September 16, 2025 | $722,587 |
| Develop AAV9 gene replacement therapy for treating mps i - project summary neurogt, inc is a start-up company founded by dr. Haiyan fu, an associate professor in the gene therapy center at university of North Carolina at chapel hill, with the mission of develop and commercialize effective gene thera | Extramural Research Programs in the Neurosciences and Neurological Disorders | July 29, 2022 | $702,684 |
| Novel aav gene therapy for treating cns neuropathy of mps iiic - project summary mps iiic is a devastating lysosomal storage disease (LSD) for which there is no definitive treatment. To address this unmet need, this proposed project is to develop an effective gene therapy (GT) product for treating m | Extramural Research Programs in the Neurosciences and Neurological Disorders | July 8, 2025 | $349,909 |
| Development of gene therapy product for treating mps iiib | Extramural Research Programs in the Neurosciences and Neurological Disorders | March 30, 2021 | $281,603 |
Questions people ask
How much federal grant money does Neurogt Inc get?
$6.9 million in 7 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Neurogt Inc the most?
The Department of Health and Human Services, with $6.9 million in 7 awards.
What is Neurogt Inc's largest federal grant?
$2.3 million under Allergy and Infectious Diseases Research, with its first action in the period on July 27, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Neurogt Inc?
Its largest are Extramural Research Programs in the Neurosciences and Neurological Disorders, Allergy and Infectious Diseases Research and Research Infrastructure Programs.
Other grant recipients in Durham
- Duke University
- Family Health International
- North Carolina Central University
- Housing Authority of the City of Durham
- Rho Federal Systems Division Inc
- City of Durham
- Families & Communities Rising, Inc.
- Lincoln Community Health Center Incorporated
Largest federal grant recipients in North Carolina · Federal grants in North Carolina